Your browser doesn't support javascript.
loading
Apatinib with etoposide capsules as a third- or further-line therapy for extensive-stage small cell lung cancer: an open-label, multicenter, single-arm phase II trial.
He, Zhen; Zhou, Hanqiong; Wang, Junsheng; Li, Ding; Zhang, Xudong; Wang, Pengyuan; Ma, Tianjiang; Zhang, Yueqiang; Tian, Chuntao; Chen, Yunfang; Zou, Minglei; Han, Yu; Xu, Cong; Ma, Shuxiang; Wang, Lili; Wu, Xuan; Chen, Gongbin; Wang, Qiming.
Afiliação
  • He Z; Department of Internal Medicine, Henan Cancer Hospital, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China.
  • Zhou H; Department of Internal Medicine, Henan Cancer Hospital, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China.
  • Wang J; Department of Medical Oncology, Anyang Cancer Hospital, Anyang, China.
  • Li D; Department of Pharmacy, Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China.
  • Zhang X; Department of Medical Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Wang P; Department of Medical Oncology, Xuchang Central Hospital, Xuchang, China.
  • Ma T; Department of Medical Oncology, Luohe Central Hospital, Luohe, China.
  • Zhang Y; Department of Medical Oncology, Zhoukou Chinese Medicine Hospital, Zhoukou, China.
  • Tian C; Department of Medical Oncology, Sanmenxia Central Hospital, Sanmenxia, China.
  • Chen Y; Department of Medical Oncology, Zhumadian Central Hospital, Zhumadian, China.
  • Zou M; Department of Medical Oncology, The Second People's Hospital of Jiaozuo, Jiaozuo, China.
  • Han Y; Department of Medical Oncology, Jiyuan People's Hospital of Henan Province, Jiyuan, China.
  • Xu C; Department of Internal Medicine, Henan Cancer Hospital, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China.
  • Ma S; Department of Internal Medicine, Henan Cancer Hospital, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China.
  • Wang L; Department of Internal Medicine, Henan Cancer Hospital, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China.
  • Wu X; Department of Internal Medicine, Henan Cancer Hospital, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China.
  • Chen G; Department of Medical Oncology, Shangqiu first People's Hospital, Shangqiu, China.
  • Wang Q; Department of Internal Medicine, Henan Cancer Hospital, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China.
Transl Lung Cancer Res ; 10(2): 889-899, 2021 Feb.
Article em En | MEDLINE | ID: mdl-33718030
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Ano de publicação: 2021 Tipo de documento: Article